HYPD · Hyperion DeFi Inc
United States · RS rating 35 · As of 2026-11-03
| Price | 3.05 USD |
|---|---|
| 1-day change | +2.7% |
| RS rating (overall / 1M / 3M / 12M) | 35 / 20 / 83 / 20 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 30 / 48 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +253.8% |
| Sales growth Q/Q | +64.0% |
| Distance from 52-week high | +52.6% |
| Market cap (USD) | $44.8M |